11 results  1 of 1 

1 The effect of atropine in preventing catheter-related pain and discomfort in patients undergoing transurethral resection due to bladder tumor; prospective randomized, controlled study
Yeliz Şahiner, Yeliz Şahiner, Arzu Akdağlı Ekici, Musa Ekici, Emre Demir
Korean J Pain.2020;33(2):176-182.   Published online 2020 April 1     DOI: http://dx.doi.org/10.3344/kjp.2020.33.2.176
      
2 Influence of solifenacin on the improvement of storage symptoms in the early period after photoselective vaporization of the prostate
Su Jin Kim, Woong Jin Bae, Sae Woong Kim
Investig Clin Urol.2019;60(6):480-487.   Published online 2019 October 22     DOI: http://dx.doi.org/10.4111/icu.2019.60.6.480
      
3 Efficacy of trospium for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study
Vinit Kumar Srivastava, Sanjay Agrawal, Sweta Anil Deshmukh, Febin Noushad, Saima Khan, Raj Kumar
Korean J Anesthesiol.2020;73(2):145-150.   Published online 2019 October 11     DOI: http://dx.doi.org/10.4097/kja.19198
      
4 Long-Term Efficacy of Mirabegron Add-On Therapy to Antimuscarinic Agents in Patients With Spinal Cord Injury
Seok-Hee Han, In Kyoung Cho, Joo Hwan Jung, Seong Ho Jang, Bum-Suk Lee
Ann Rehabil Med.2019;43(1):54-61.   Published online 2019 February 28     DOI: http://dx.doi.org/10.5535/arm.2019.43.1.54
      
5 Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma
René Aalbers, Hae-Sim Park
Allergy Asthma Immunol Res.2017;9(5):386-393.   Published online 2017 April 24     DOI: http://dx.doi.org/10.4168/aair.2017.9.5.386
      
6 Long-term adherence to antimuscarinic drugs when treating overactive bladder in the older: Subjective reason and objective factors
Kirill Vladimirovich Kosilov, Sergay Alexandrovich Loparev, Irina Gennadyevna Kuzina, Boris Izrailevich Geltser, Olga Viktorovna Shakirova, Natalya Sergeevna Zhuravskaya, Alexandra Lobodenko
Investig Clin Urol.2017;58(2):109-116.   Published online 2017 February 1     DOI: http://dx.doi.org/10.4111/icu.2017.58.2.109
      
7 Persistence and compliance with medication management in the treatment of overactive bladder
Tae Heon Kim, Kyu-Sung Lee
Investig Clin Urol.2016;57(2):84-93.   Published online 2016 March 11     DOI: http://dx.doi.org/10.4111/icu.2016.57.2.84
      
8 Factors affecting medication discontinuation in patients with overactive bladder symptoms
Eun-Jung Shim, Eun-Hee Yoo, Young-Mi Kim, Donguk Kim
Obstet Gynecol Sci.2015;58(6):507-513.   Published online 2015 November 16     DOI: http://dx.doi.org/10.5468/ogs.2015.58.6.507
      
9 Bladder Wall Thickness is Associated with Responsiveness of Storage Symptoms to Alpha-Blockers in Men with Lower Urinary Tract Symptoms
Jung Soo Park, Ho Won Lee, Seung Wook Lee, Hong Sang Moon, Hae Young Park, Yong Tae Kim
Korean J Urol.2012;53(7):487-491.   Published online 2012 July 19     DOI: http://dx.doi.org/10.4111/kju.2012.53.7.487
      
10 Issues on Safety of Long-Acting Muscarinic Antagonist
Yang Deok Lee, Yongseon Cho, Min Soo Han
Tuberc Respir Dis.2011;70(5):384-389.   Published online 2011 May 31     DOI: http://dx.doi.org/10.4046/trd.2011.70.5.384
      
11 Effects of Intravesical Instillation of Antimuscarinics on Bladder Overactivity Induced by Intravesical Instillation of Adenosine Triphosphate in Rats
Sang Bong Lee, Jae Won Lee, Yong Tae Kim
Korean J Urol.2009;50(4):396-400.   Published online 2009 April 27     DOI: http://dx.doi.org/10.4111/kju.2009.50.4.396
      

 1 of 1